| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $475,730 ) |
| | 2024 | 2024 | RESEARCH FOR DEVELOPMENT | KG 11 AVE | KIGALI | | | | RWA | UG1CA284908 | Rwanda CASCADE Clinical Trials Site for cervical cancer prevention | 002 | 2 | NIH | 9/16/2024 | $124,361 |
| | 2024 | 2024 | RESEARCH FOR DEVELOPMENT | KG 11 AVE | KIGALI | | | | RWA | UG1CA284908 | Rwanda CASCADE Clinical Trials Site for cervical cancer prevention | 001 | 2 | NIH | 9/9/2024 | $226,371 |
| | 2024 | 2024 | RESEARCH FOR DEVELOPMENT | KG 11 AVE | KIGALI | | | | RWA | UG1CA284908 | Rwanda CASCADE Clinical Trials Site for cervical cancer prevention | 003 | 2 | NIH | 9/18/2024 | $124,998 |
| | 2024 | 2023 | RESEARCH FOR DEVELOPMENT | KG 11 AVE | KIGALI | | | | RWA | UG1CA284908 | Rwanda CASCADE Clinical Trials Site for cervical cancer prevention | 000 | 1 | NIH | 10/16/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $226,299 ) |
| | 2023 | 2023 | RESEARCH FOR DEVELOPMENT | KG 11 AVE | KIGALI | | | | RWA | UG1CA284908 | Rwanda CASCADE Clinical Trials Site for cervical cancer prevention | 000 | 1 | NIH | 9/22/2023 | $226,299 |
|
|
